7-83392656-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_012431.3(SEMA3E):āc.1566T>Cā(p.Tyr522Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00709 in 1,613,842 control chromosomes in the GnomAD database, including 667 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.035 ( 320 hom., cov: 31)
Exomes š: 0.0041 ( 347 hom. )
Consequence
SEMA3E
NM_012431.3 synonymous
NM_012431.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.666
Genes affected
SEMA3E (HGNC:10727): (semaphorin 3E) Semaphorins are a large family of conserved secreted and membrane associated proteins which possess a semaphorin (Sema) domain and a PSI domain (found in plexins, semaphorins and integrins) in the N-terminal extracellular portion. Based on sequence and structural similarities, semaphorins are put into eight classes: invertebrates contain classes 1 and 2, viruses have class V, and vertebrates contain classes 3-7. Semaphorins serve as axon guidance ligands via multimeric receptor complexes, some (if not all) containing plexin proteins. This gene encodes a class 4 semaphorin. This gene encodes a class 3 semaphorin. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 7-83392656-A-G is Benign according to our data. Variant chr7-83392656-A-G is described in ClinVar as [Benign]. Clinvar id is 416919.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.666 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.12 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SEMA3E | NM_012431.3 | c.1566T>C | p.Tyr522Tyr | synonymous_variant | 14/17 | ENST00000643230.2 | NP_036563.1 | |
SEMA3E | NM_001178129.2 | c.1386T>C | p.Tyr462Tyr | synonymous_variant | 14/17 | NP_001171600.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SEMA3E | ENST00000643230.2 | c.1566T>C | p.Tyr522Tyr | synonymous_variant | 14/17 | NM_012431.3 | ENSP00000496491.1 | |||
SEMA3E | ENST00000642232.1 | c.1566T>C | p.Tyr522Tyr | synonymous_variant | 14/17 | ENSP00000494064.1 | ||||
SEMA3E | ENST00000643441.1 | n.1551T>C | non_coding_transcript_exon_variant | 14/17 |
Frequencies
GnomAD3 genomes AF: 0.0353 AC: 5363AN: 152028Hom.: 315 Cov.: 31
GnomAD3 genomes
AF:
AC:
5363
AN:
152028
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00949 AC: 2382AN: 250944Hom.: 156 AF XY: 0.00700 AC XY: 949AN XY: 135590
GnomAD3 exomes
AF:
AC:
2382
AN:
250944
Hom.:
AF XY:
AC XY:
949
AN XY:
135590
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00415 AC: 6059AN: 1461696Hom.: 347 Cov.: 34 AF XY: 0.00368 AC XY: 2677AN XY: 727154
GnomAD4 exome
AF:
AC:
6059
AN:
1461696
Hom.:
Cov.:
34
AF XY:
AC XY:
2677
AN XY:
727154
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0354 AC: 5388AN: 152146Hom.: 320 Cov.: 31 AF XY: 0.0339 AC XY: 2523AN XY: 74386
GnomAD4 genome
AF:
AC:
5388
AN:
152146
Hom.:
Cov.:
31
AF XY:
AC XY:
2523
AN XY:
74386
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
36
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 06, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Dec 10, 2018 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
CHARGE syndrome Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at